NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
Depending on the exchange, the stock ticker may vary. For instance, on exchange Novabay Pharmaceuticals stocks are traded under the ticker B9P1.F.
When is the next Novabay Pharmaceuticals earnings date?▼
Novabay Pharmaceuticals is going to release the next earnings report on May 07, 2026.
What were Novabay Pharmaceuticals earnings last quarter?▼
B9P1.F earnings for the last quarter are -0.99 EUR per share, whereas the estimation was -0.91 EUR resulting in a -9.52% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Novabay Pharmaceuticals revenue for the last year?▼
Novabay Pharmaceuticals revenue for the last year amounts to 18.55M EUR.
What is Novabay Pharmaceuticals net income for the last year?▼
B9P1.F net income for the last year is -16.29M EUR.
Does Novabay Pharmaceuticals pay dividends?▼
Yes, B9P1.F dividends are paid en. The last dividend per share was 3.4 EUR. As of today, Dividend Yield (FWD)% is 0%.
When did Novabay Pharmaceuticals complete a stock split?▼
The last stock split for Novabay Pharmaceuticals was on February 23, 2026 with a ratio of 1:5.